Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberto Bei

Showing results (1-10 of 150) with videos related to

Pageof 15
Sort By:
International Journal of Molecular Sciences|April 13, 2023
The Effect of Dietary Factors on CancerMonica Benvenuto, Roberto Bei
International Journal of Molecular Sciences|April 28, 2023
Novel Therapeutic Targets for Tumor Microenvironment in CancerRoberto Bei, Laura Masuelli
Journal of Biomedicine & Biotechnology|July 10, 2010
TAA polyepitope DNA-based vaccines: a potential tool for cancer therapyRoberto Bei, Antonio Scardino
Frontiers in Bioscience (Landmark Edition)|October 6, 2019
Alpha-fetoprotein is an autoantigen in hepatocellular carcinoma and juvenile Batten diseaseRoberto Bei, Gerald Jude Mizejewski
Recent Patents on Anti-Cancer Drug Discovery|July 3, 2010
The use of temozolomide for the treatment of malignant tumors: clinical evidence and molecular mechanisms of actionRoberto Bei, Laura Marzocchella, Mario Turriziani
International Journal of Molecular Sciences|December 24, 2021
Infection by High-Risk Human Papillomaviruses, Epithelial-to-Mesenchymal Transition and Squamous Pre-Malignant or Malignant Lesions of the Uterine Cervix: A Series of Chained Events?Giovanni Barillari, Roberto Bei, Vittorio Manzari, et al.
Current Medicinal Chemistry|May 14, 2008
Molecular targets and targeted therapies for malignant mesotheliomaCamilla Palumbo, Roberto Bei, Antonio Procopio, et al.
Turkish Journal of Urology|December 2, 2015
Undifferentiated metastatic renal cell carcinoma presenting as a cutaneous nodular lesionGiovanni Paolino, Paolo Lido, Roberto Bei, et al.
International Journal of Molecular Sciences|February 13, 2026
Fibronectin Is a Likely Therapeutic Target Shared by Oral and Breast CarcinomasSilvia Pomella, Roberto Bei, Ombretta Melaiu, et al.
International Journal of Oncology|May 9, 2009
Inhibition of Mek 1/2 kinase activity and stimulation of melanogenesis by 5,7-dimethoxycoumarin treatment of melanoma cellsDaniela Alesiani, Rosella Cicconi, Maurizio Mattei, et al.
Pageof 15

Showing results (1-10 of 150) with videos related to

Sort By:
Pageof 15
International Journal of Molecular Sciences|April 13, 2023
The Effect of Dietary Factors on CancerMonica Benvenuto, Roberto Bei
International Journal of Molecular Sciences|April 28, 2023
Novel Therapeutic Targets for Tumor Microenvironment in CancerRoberto Bei, Laura Masuelli
Journal of Biomedicine & Biotechnology|July 10, 2010
TAA polyepitope DNA-based vaccines: a potential tool for cancer therapyRoberto Bei, Antonio Scardino
Frontiers in Bioscience (Landmark Edition)|October 6, 2019
Alpha-fetoprotein is an autoantigen in hepatocellular carcinoma and juvenile Batten diseaseRoberto Bei, Gerald Jude Mizejewski
Recent Patents on Anti-Cancer Drug Discovery|July 3, 2010
The use of temozolomide for the treatment of malignant tumors: clinical evidence and molecular mechanisms of actionRoberto Bei, Laura Marzocchella, Mario Turriziani
International Journal of Molecular Sciences|December 24, 2021
Infection by High-Risk Human Papillomaviruses, Epithelial-to-Mesenchymal Transition and Squamous Pre-Malignant or Malignant Lesions of the Uterine Cervix: A Series of Chained Events?Giovanni Barillari, Roberto Bei, Vittorio Manzari, et al.
Current Medicinal Chemistry|May 14, 2008
Molecular targets and targeted therapies for malignant mesotheliomaCamilla Palumbo, Roberto Bei, Antonio Procopio, et al.
Turkish Journal of Urology|December 2, 2015
Undifferentiated metastatic renal cell carcinoma presenting as a cutaneous nodular lesionGiovanni Paolino, Paolo Lido, Roberto Bei, et al.
International Journal of Molecular Sciences|February 13, 2026
Fibronectin Is a Likely Therapeutic Target Shared by Oral and Breast CarcinomasSilvia Pomella, Roberto Bei, Ombretta Melaiu, et al.
International Journal of Oncology|May 9, 2009
Inhibition of Mek 1/2 kinase activity and stimulation of melanogenesis by 5,7-dimethoxycoumarin treatment of melanoma cellsDaniela Alesiani, Rosella Cicconi, Maurizio Mattei, et al.
Pageof 15